Company / Revenue
Jaguar Health, Inc. Revenue History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$11.7M
FY2025
5-year range
$4.3M / $11.7M
FY2021-FY2025
Trend
+19.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 9 years, ranging from $0 in FY2015 to $12M in FY2025.
Based on SEC 10-K filings.
$12M in FY2025 with a 5-year CAGR of +15.1%.
Improved from $4M to $12M over the past 3 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +39.2%
- 5-Year CAGR
- +15.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +15.1%, indicating consistent growth.
- In FY2025, revenue increased 19.8% year-over-year.
- Lowest revenue in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.7M | +19.8% |
| FY2024 | $9.8M | +125.2% |
| FY2022 | $4.3M | -24.9% |
| FY2020 | $5.8M | +30.8% |
| FY2019 | $4.4M | +1.3% |
| FY2018 | $4.4M | +2981.6% |
| FY2017 | $141.5K | -45.2% |
| FY2016 | $258.4K | - |
| FY2015 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026